Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024

Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociación Mexicana de Gastroenterología, 2024

Introduction: The aim of this position statement is to provide health professionals with an updated and evidence-based guideline for the pharmacologic management of irritable bowel syndrome (IBS) in Mexico. Material and methods: A literature review was conducted that included relevant guidelines and...

Full description

Saved in:
Bibliographic Details
Main Authors: J.M. Remes-Troche, E. Coss-Adame, M. Schmulson, K.R. García-Zermeño, M. Amieva-Balmori, R. Carmona-Sánchez, O. Gómez-Escudero, P.C. Gómez-Castaños, M.E. Icaza-Chávez, A. López-Colombo, E.C. Morel-Cerda, M.Á. Valdovinos-Díaz, L.R. Valdovinos-García, A.S. Villar-Chávez
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Revista de Gastroenterología de México (English Edition)
Subjects:
Síndrome de intestino irritable
Diarrea
Estreñimiento
Antiespasmódicos
Neuromoduladores
Rifaximina
Online Access:http://www.sciencedirect.com/science/article/pii/S2255534X25000155
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2255534X25000155

Similar Items